Litcius/Paper detail

Short-term treatment with RNA interference therapy, JNJ-3989, results in sustained hepatitis B surface antigen supression in patients with chronic hepatitis B receiving nucleos(t)ide analogue treatment

Edward Gane, Stephen Locarnini, Tien Huey Lim, Simone I. Strasser, William Sievert, Wendy Cheng, Alexander Thompson, Bruce D. Given, Thomas Schluep, James Hamilton, Michael Biermer, Ronald Kalmeijer, Maria Beumont-Mauviel, Oliver Lenz, Gavin Cloherty, Danny Ka‐Ho Wong, Christian Schwabe, Kathy Merlock Jackson, Carlo Ferrari, Ching‐Lung Lai, Robert G. Gish, Man‐Fung Yuen

2020Journal of Hepatology40 citationsDOI

Topics & Concepts

MedicineChronic hepatitisHepatitis BGastroenterologyVirologyInternal medicineVirusHepatitis B Virus StudiesVirus-based gene therapy researchPancreatic and Hepatic Oncology Research
Short-term treatment with RNA interference therapy, JNJ-3989, results in sustained hepatitis B surface antigen supression in patients with chronic hepatitis B receiving nucleos(t)ide analogue treatment | Litcius